<DOC>
	<DOCNO>NCT00691353</DOCNO>
	<brief_summary>Cross - Sectional study require one visit investigator office data collection . - Target Group : Patients suffer Bipolar Disorder Type 1 . - YMRS - HAMILTON GAF scale go use assess clinical outcome . The finding go base different score report Specialists ( patient start use therapy atypical antipsychotic / time visit actually take place cause study . ) We predefine time period patient use atypical antipsychotic minimum ( 2 month ) . - The first 9 consecutive patient visit Specialist meet entry criterion sign ICF recruit study .</brief_summary>
	<brief_title>Subjective Well Being Patients Receiving Atypical Antipsychotics Monotherapy Cotherapy With Mood Stabilizers</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Patients diagnose Bipolar Disorder Type 1 accord diagnostic criterion DSM IV Patients start therapy atypical antipsychotic monotherapy cotherapy mood stabilizer last three month , complete 2 full month therapy . Patients anxiety disorder recruit study unless dominant . Patients use antidepressant medication Patients treat depot antipsychotic last quarter enrollment study . Patients addict toxic substance . Patients suffer serious disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>social functioning</keyword>
	<keyword>mood stabilizer</keyword>
	<keyword>Bipolar Disorder Type I</keyword>
	<keyword>atypical antipsychotic</keyword>
	<keyword>monotherapy</keyword>
	<keyword>cotherapy</keyword>
</DOC>